Shah VN, Dex T, Meneghini L, Rodrigues A, et al. Treatment satisfaction and time in range after 16 weeks of treatment with iGlarLixi in insulin-naive adults with suboptimally controlled type 2 diabetes. Diabetes Obes Metab 2025 Feb 14. doi: 10.1111/dom.16251.
PMID: 39950217